Liming Shao

14PUBLICATIONS
15CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsOrganometallic chemistryCharacterisation of biological macromoleculesFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 29, 2026
Pharmacological Characterization of SLL-022CCP, a Selective κ‑Opioid Receptor Agonist with Potent Antinociceptive Effects and Low Central Side Effects.

|Dec 31, 2025
Correction to "Structure-Activity Relationship of <i>N</i>-Cyclopropylmethyl-7α-[<i>para</i>-(arylcarboxamido)phenyl]-6,14-<i>endo</i>ethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists".

Linghui Kong, Songyu Yao, Denggao Zhang

|Jul 28, 2025
Structure-Activity Relationship of <i>N</i>-Cyclopropylmethyl-7α-[<i>para</i>-(arylcarboxamido)phenyl]-6,14-<i>endo</i>ethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists.

Linghui Kong, Songyu Yao, Denggao Zhang

|Apr 22, 2024
Discovery of an Ortho-Substituted <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-<i>endo</i>ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect.

Zixiang Li, Rufeng Ye, Qian He

|Mar 12, 2024
Synthesis of easily-modified and useful dibenzo-[<i>b,d</i>]azepines by palladium(II)-catalyzed cyclization/addition with a green solvent.

Hua Cheng, Rongqi Liu, Shengyang Fang

|Aug 25, 2022
Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects <i>In Vivo</i> Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core.

Qianqian Liang, Zhen Qiao, Qiqi Zhou

Pageof 3

Frequent Collaborators

7 joint publications

Wei Fu

5 joint publications

Wei Li

4 joint publications

Linghui Kong

3 joint publications

Qiong Xie